Copyright Reports & Markets. All rights reserved.

Global Neurotechnology Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Neurotechnology Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Neuroprosthetics
    • 1.3.3 Neural Stimulators
    • 1.3.4 Neurorehabilitation
    • 1.3.5 Neurosensing
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Neurotechnology Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Parkinson's Disease
    • 1.4.3 Cerebral Palsy
    • 1.4.4 Cognitive Disorders
    • 1.4.5 Epilepsy
    • 1.4.6 Incontinence
    • 1.4.7 Traumatic Brain Injury
    • 1.4.8 Others
  • 1.5 Global Neurotechnology Device Market Size & Forecast
    • 1.5.1 Global Neurotechnology Device Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Neurotechnology Device Sales Quantity (2021-2032)
    • 1.5.3 Global Neurotechnology Device Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Neurotechnology Device Product and Services
    • 2.1.4 Abbott Laboratories Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Laboratories Recent Developments/Updates
  • 2.2 Advanced Bionics
    • 2.2.1 Advanced Bionics Details
    • 2.2.2 Advanced Bionics Major Business
    • 2.2.3 Advanced Bionics Neurotechnology Device Product and Services
    • 2.2.4 Advanced Bionics Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Advanced Bionics Recent Developments/Updates
  • 2.3 Axonics Modulation Technologies
    • 2.3.1 Axonics Modulation Technologies Details
    • 2.3.2 Axonics Modulation Technologies Major Business
    • 2.3.3 Axonics Modulation Technologies Neurotechnology Device Product and Services
    • 2.3.4 Axonics Modulation Technologies Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Axonics Modulation Technologies Recent Developments/Updates
  • 2.4 Boston Scientific Corp
    • 2.4.1 Boston Scientific Corp Details
    • 2.4.2 Boston Scientific Corp Major Business
    • 2.4.3 Boston Scientific Corp Neurotechnology Device Product and Services
    • 2.4.4 Boston Scientific Corp Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Boston Scientific Corp Recent Developments/Updates
  • 2.5 Laborie
    • 2.5.1 Laborie Details
    • 2.5.2 Laborie Major Business
    • 2.5.3 Laborie Neurotechnology Device Product and Services
    • 2.5.4 Laborie Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Laborie Recent Developments/Updates
  • 2.6 Cleveland Medical Devices
    • 2.6.1 Cleveland Medical Devices Details
    • 2.6.2 Cleveland Medical Devices Major Business
    • 2.6.3 Cleveland Medical Devices Neurotechnology Device Product and Services
    • 2.6.4 Cleveland Medical Devices Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Cleveland Medical Devices Recent Developments/Updates
  • 2.7 EndoStim
    • 2.7.1 EndoStim Details
    • 2.7.2 EndoStim Major Business
    • 2.7.3 EndoStim Neurotechnology Device Product and Services
    • 2.7.4 EndoStim Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 EndoStim Recent Developments/Updates
  • 2.8 LivaNova
    • 2.8.1 LivaNova Details
    • 2.8.2 LivaNova Major Business
    • 2.8.3 LivaNova Neurotechnology Device Product and Services
    • 2.8.4 LivaNova Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 LivaNova Recent Developments/Updates
  • 2.9 Medtronic
    • 2.9.1 Medtronic Details
    • 2.9.2 Medtronic Major Business
    • 2.9.3 Medtronic Neurotechnology Device Product and Services
    • 2.9.4 Medtronic Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Medtronic Recent Developments/Updates
  • 2.10 Natus Medical Incorporated
    • 2.10.1 Natus Medical Incorporated Details
    • 2.10.2 Natus Medical Incorporated Major Business
    • 2.10.3 Natus Medical Incorporated Neurotechnology Device Product and Services
    • 2.10.4 Natus Medical Incorporated Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Natus Medical Incorporated Recent Developments/Updates
  • 2.11 Neuronetics
    • 2.11.1 Neuronetics Details
    • 2.11.2 Neuronetics Major Business
    • 2.11.3 Neuronetics Neurotechnology Device Product and Services
    • 2.11.4 Neuronetics Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Neuronetics Recent Developments/Updates
  • 2.12 NeuroSigma
    • 2.12.1 NeuroSigma Details
    • 2.12.2 NeuroSigma Major Business
    • 2.12.3 NeuroSigma Neurotechnology Device Product and Services
    • 2.12.4 NeuroSigma Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 NeuroSigma Recent Developments/Updates
  • 2.13 Restorative Therapies
    • 2.13.1 Restorative Therapies Details
    • 2.13.2 Restorative Therapies Major Business
    • 2.13.3 Restorative Therapies Neurotechnology Device Product and Services
    • 2.13.4 Restorative Therapies Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Restorative Therapies Recent Developments/Updates
  • 2.14 Zynex Medical
    • 2.14.1 Zynex Medical Details
    • 2.14.2 Zynex Medical Major Business
    • 2.14.3 Zynex Medical Neurotechnology Device Product and Services
    • 2.14.4 Zynex Medical Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Zynex Medical Recent Developments/Updates
  • 2.15 Cochlear Limited
    • 2.15.1 Cochlear Limited Details
    • 2.15.2 Cochlear Limited Major Business
    • 2.15.3 Cochlear Limited Neurotechnology Device Product and Services
    • 2.15.4 Cochlear Limited Neurotechnology Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Cochlear Limited Recent Developments/Updates

3 Competitive Environment: Neurotechnology Device by Manufacturer

  • 3.1 Global Neurotechnology Device Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Neurotechnology Device Revenue by Manufacturer (2021-2026)
  • 3.3 Global Neurotechnology Device Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Neurotechnology Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Neurotechnology Device Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Neurotechnology Device Manufacturer Market Share in 2025
  • 3.5 Neurotechnology Device Market: Overall Company Footprint Analysis
    • 3.5.1 Neurotechnology Device Market: Region Footprint
    • 3.5.2 Neurotechnology Device Market: Company Product Type Footprint
    • 3.5.3 Neurotechnology Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Neurotechnology Device Market Size by Region
    • 4.1.1 Global Neurotechnology Device Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Neurotechnology Device Consumption Value by Region (2021-2032)
    • 4.1.3 Global Neurotechnology Device Average Price by Region (2021-2032)
  • 4.2 North America Neurotechnology Device Consumption Value (2021-2032)
  • 4.3 Europe Neurotechnology Device Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Neurotechnology Device Consumption Value (2021-2032)
  • 4.5 South America Neurotechnology Device Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Neurotechnology Device Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Neurotechnology Device Sales Quantity by Type (2021-2032)
  • 5.2 Global Neurotechnology Device Consumption Value by Type (2021-2032)
  • 5.3 Global Neurotechnology Device Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Neurotechnology Device Sales Quantity by Application (2021-2032)
  • 6.2 Global Neurotechnology Device Consumption Value by Application (2021-2032)
  • 6.3 Global Neurotechnology Device Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Neurotechnology Device Sales Quantity by Type (2021-2032)
  • 7.2 North America Neurotechnology Device Sales Quantity by Application (2021-2032)
  • 7.3 North America Neurotechnology Device Market Size by Country
    • 7.3.1 North America Neurotechnology Device Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Neurotechnology Device Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Neurotechnology Device Sales Quantity by Type (2021-2032)
  • 8.2 Europe Neurotechnology Device Sales Quantity by Application (2021-2032)
  • 8.3 Europe Neurotechnology Device Market Size by Country
    • 8.3.1 Europe Neurotechnology Device Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Neurotechnology Device Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Neurotechnology Device Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Neurotechnology Device Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Neurotechnology Device Market Size by Region
    • 9.3.1 Asia-Pacific Neurotechnology Device Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Neurotechnology Device Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Neurotechnology Device Sales Quantity by Type (2021-2032)
  • 10.2 South America Neurotechnology Device Sales Quantity by Application (2021-2032)
  • 10.3 South America Neurotechnology Device Market Size by Country
    • 10.3.1 South America Neurotechnology Device Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Neurotechnology Device Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Neurotechnology Device Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Neurotechnology Device Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Neurotechnology Device Market Size by Country
    • 11.3.1 Middle East & Africa Neurotechnology Device Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Neurotechnology Device Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Neurotechnology Device Market Drivers
  • 12.2 Neurotechnology Device Market Restraints
  • 12.3 Neurotechnology Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Neurotechnology Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Neurotechnology Device
  • 13.3 Neurotechnology Device Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Neurotechnology Device Typical Distributors
  • 14.3 Neurotechnology Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Neurotechnology Device market size was valued at US$ 13870 million in 2025 and is forecast to a readjusted size of US$ 22770 million by 2032 with a CAGR of 7.4% during review period.
    Neurotechnology is any technology that has a fundamental influence on how people understand the brain and various aspects of consciousness, thought, and higher order activities in the brain. It also includes technologies that are designed to improve and repair brain function and allow researchers and clinicians to visualize the brain. The digital health sector matures from basic tracking apps into highly regulated medical devices, right now there is a bleeding edge technologies being developed that blur the lines between computers and biology and a growing share of these startups are beginning to target the brain. The burgeoning field of neurotechnology involves brain-machine interfaces, neuroproteins, neurostimulation, neuromonitoring, and implantable devices intended to not only augment nervous system activity, but expand its capabilities.
    The global neurotechnology device market refers to the industry involved in the development, manufacturing, distribution, and usage of devices and technologies that are used in the diagnosis, treatment, and management of neurological disorders and conditions. Neurotechnology devices encompass a wide range of products, including neurostimulation devices, neurofeedback devices, brain-computer interfaces, neurodiagnostic devices, and neuroprosthetics. Here’s an overview of the market:
    Market Overview: The neurotechnology device market is a rapidly growing sector within the broader medical device industry. It encompasses a diverse range of devices and technologies that aim to understand brain function, diagnose neurological disorders, and provide therapeutic interventions for various neurological conditions.
    Market Segmentation: The market can be segmented based on the type of device, including neurostimulation devices (such as deep brain stimulation, spinal cord stimulation, and transcranial magnetic stimulation devices), neurofeedback devices, brain-computer interfaces, neurodiagnostic devices (such as EEG, MRI, and CT scanning), and neuroprosthetics (such as cochlear implants and deep brain implants).
    Neurological Conditions: Neurotechnology devices are used in the diagnosis and treatment of various neurological conditions, including epilepsy, Parkinson’s disease, Alzheimer’s disease, stroke, chronic pain, depression, and others. These devices aim to improve patient outcomes, enhance quality of life, and potentially restore lost neurological function.
    Technological Advancements: Advances in neuroscience, neuroimaging, computational algorithms, and miniaturization of devices have contributed to the rapid growth of the neurotechnology market. Innovations in neurostimulation techniques, real-time brain monitoring, wearable and implantable devices, and neurofeedback technologies are driving market expansion.
    Key Players: The neurotechnology device market is highly competitive, with several established companies and emerging startups operating in the field. Key players include Medtronic, Abbott Laboratories, Boston Scientific, Cochlear Limited, NeuroPace, and others. These companies invest in research and development, clinical trials, and marketing to introduce new and improved neurotechnology devices.
    Market Dynamics: Factors such as increasing prevalence of neurological disorders, growing aging population, rising awareness, technological advancements, and favorable reimbursement policies are driving the market growth. However, challenges such as high costs associated with devices, stringent regulatory processes, and ethical considerations in brain-computer interface technology can affect market progression.
    Market Outlook: The global neurotechnology device market is expected to continue its growth trajectory in the coming years. Increasing investments in research and development, collaborations between academia and industry, and the focus on personalized medicine are likely to drive innovation and the introduction of advanced neurotechnology devices.
    Ethical and Regulatory Considerations: The use of neurotechnology devices raises ethical concerns related to data privacy, informed consent, and potential misuse. Regulatory agencies closely monitor the safety and efficacy of these devices, ensuring adherence to quality standards and ethical principles.
    This report is a detailed and comprehensive analysis for global Neurotechnology Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Neurotechnology Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Neurotechnology Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Neurotechnology Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Neurotechnology Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Neurotechnology Device
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Neurotechnology Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Advanced Bionics, Axonics Modulation Technologies, Boston Scientific Corp, Laborie, Cleveland Medical Devices, EndoStim, LivaNova, Medtronic, Natus Medical Incorporated, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Neurotechnology Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Neuroprosthetics
    Neural Stimulators
    Neurorehabilitation
    Neurosensing
    Market segment by Application
    Parkinson's Disease
    Cerebral Palsy
    Cognitive Disorders
    Epilepsy
    Incontinence
    Traumatic Brain Injury
    Others
    Major players covered
    Abbott Laboratories
    Advanced Bionics
    Axonics Modulation Technologies
    Boston Scientific Corp
    Laborie
    Cleveland Medical Devices
    EndoStim
    LivaNova
    Medtronic
    Natus Medical Incorporated
    Neuronetics
    NeuroSigma
    Restorative Therapies
    Zynex Medical
    Cochlear Limited
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Neurotechnology Device product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Neurotechnology Device, with price, sales quantity, revenue, and global market share of Neurotechnology Device from 2021 to 2026.
    Chapter 3, the Neurotechnology Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Neurotechnology Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Neurotechnology Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Neurotechnology Device.
    Chapter 14 and 15, to describe Neurotechnology Device sales channel, distributors, customers, research findings and conclusion.

    Buy now